-
Loading metrics
Open Access
Peer-reviewed
Research Article
The Use of Antihypertensive Medication and the Risk of Breast Cancer in a Case-Control Study in a Spanish Population: The MCC-Spain Study
-
Inés Gómez-Acebo ,
* E-mail: gomezai@unican.es
Affiliations CIBER Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain, University of Cantabria–IDIVAL, Santander, Spain
⨯ -
Trinidad Dierssen-Sotos,
Affiliations CIBER Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain, University of Cantabria–IDIVAL, Santander, Spain
⨯ -
Camilo Palazuelos,
Affiliation University of Cantabria–IDIVAL, Santander, Spain
⨯ -
Beatriz Pérez-Gómez,
Affiliations CIBER Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain, Cancer and Environmental Epidemiology Unit, National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain, Cancer Epidemiology Research Group, Oncology and Hematology Area, IIS Puerta de Hierro (IDIPHIM), Madrid, Spain
⨯ -
Virginia Lope,
Affiliations CIBER Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain, Cancer and Environmental Epidemiology Unit, National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain, Cancer Epidemiology Research Group, Oncology and Hematology Area, IIS Puerta de Hierro (IDIPHIM), Madrid, Spain
⨯ -
Ignasi Tusquets,
Affiliations Servei d'Oncologia Mèdica, Hospital del Mar, Barcelona, Spain, Cancer Research Program IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain, Universitat Autònoma de Barcelona, Barcelona, Spain
⨯ -
M. Henar Alonso,
Affiliations CIBER Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain, Cancer Prevention and Control Program, Catalan Institute of Oncology-IDIBELL, and University of Barcelona, Barcelona, Spain
⨯ -
Victor Moreno,
Affiliations CIBER Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain, Cancer Prevention and Control Program, Catalan Institute of Oncology-IDIBELL, and University of Barcelona, Barcelona, Spain
⨯ -
Pilar Amiano,
Affiliations CIBER Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain, Public Health Division of Gipuzkoa, Biodonostia Research Institute, Guipuzkoa, Spain
⨯ -
Antonio José Molina de la Torre,
Affiliations Área de Medicina Preventiva y Salud Pública, Departamento de Ciencias Biomédicas, Universidad de León, León, España, Grupo de Investigación en Interacciones Gen-Ambiente y Salud (GIIGAS), Universidad de León, León, España
⨯ -
Aurelio Barricarte,
Affiliations Navarra Public Health Institute, Pamplona, Spain, Navarra Institute for Health Research (IdiSNA) Pamplona, Pamplona, Spain
⨯ -
Adonina Tardon,
Affiliations CIBER Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain, IUOPA, Universidad de Oviedo, Oviedo, Spain
⨯ -
Antonio Camacho,
Affiliations Hospital Juan Ramon Jimenez, Andalusian Health Service, Huelva, España, Research Center for Health and the Environment (CYSMA), Universidad de Huelva, Huelva, España
⨯ -
Rosana Peiro-Perez,
Affiliations CIBER Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain, Area de Cáncer y Salud Pública, Fundación FISABIO- Salud Pública, Valencia, Spain
⨯ -
Rafael Marcos-Gragera,
Affiliation Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia and Descriptive Epidemiology, Genetics and Cancer Prevention Group [Girona Biomedical Research Institute (IdIBGi)], Catalan Institute of Oncology, Girona, Spain
⨯ -
Montse Muñoz,
Affiliation Translational Genomics and Targeted Therapeutics in Solid Tumors (IDIBAPS), Barcelona, Spain
⨯ -
Maria Jesus Michelena-Echeveste,
Affiliation Onkologikoa- Oncology Institute Gipuzkoa, Guipuzkoa, Spain
⨯ -
Luis Ortega Valin,
Affiliation Pharmacy Service, Complex assistive university Leon, Leon, Spain
⨯ -
Marcela Guevara,
Affiliations CIBER Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain, Grupo de Investigación en Interacciones Gen-Ambiente y Salud (GIIGAS), Universidad de León, León, España, Navarra Institute for Health Research (IdiSNA), Pamplona, Spain
⨯ -
Gemma Castaño-Vinyals,
Affiliations CIBER Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain, Universitat Pompeu Fabra (UPF), Barcelona, Spain, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
⨯ -
Nuria Aragonés,
Affiliations CIBER Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain, Cancer and Environmental Epidemiology Unit, National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain, Cancer Epidemiology Research Group, Oncology and Hematology Area, IIS Puerta de Hierro (IDIPHIM), Madrid, Spain
⨯ -
Manolis Kogevinas,
Affiliations CIBER Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain, Universitat Pompeu Fabra (UPF), Barcelona, Spain
⨯ -
Marina Pollán,
Affiliations CIBER Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain, Cancer and Environmental Epidemiology Unit, National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain, Cancer Epidemiology Research Group, Oncology and Hematology Area, IIS Puerta de Hierro (IDIPHIM), Madrid, Spain
⨯ - [ ... ],
-
Javier Llorca
Affiliations CIBER Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain, University of Cantabria–IDIVAL, Santander, Spain
⨯ - [ view all ]
- [ view less ]
The Use of Antihypertensive Medication and the Risk of Breast Cancer in a Case-Control Study in a Spanish Population: The MCC-Spain Study
- Inés Gómez-Acebo,
- Trinidad Dierssen-Sotos,
- Camilo Palazuelos,
- Beatriz Pérez-Gómez,
- Virginia Lope,
- Ignasi Tusquets,
- M. Henar Alonso,
- Victor Moreno,
- Pilar Amiano,
- Antonio José Molina de la Torre
- Published: August 10, 2016
- https://doi.org/10.1371/journal.pone.0159672